University Health Network
Toronto, Ontario, M5G 2M9, Canada
NCT Number: NCT00259584
All patients with symptomatic malignant SVCO deemed suitable for treatment either with radiation therapy or by stenting will be eligible. They will receive whichever treatment is deemed most clinically appropriate. Symptomatic response, time to onset of palliation, duration of symptom control and survival will be assessed.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Toronto, Ontario, M5G 2M9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
University Health Network, Toronto
Other
A Prospective Longitudinal Study of the Management and Outcome of Superior Vena Caval Obstruction (SVCO)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04637334
Cardiovascular Diseases, Superior Vena Cava Syndrome
Dallas, Texas, United States
View Trial DetailsNCT03824366
Cardiovascular Diseases, Digestive System Diseases
St Louis, Missouri, United States
View Trial DetailsNCT00200356
Brain Diseases, Brain Infarction
View Trial DetailsNCT02157987
Cardiovascular Abnormalities, Cardiovascular Diseases
Caen, France
View Trial Details